CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+6.61%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.04B
AUM Growth
+$1.04B
(+19%)
Cap. Flow
+$84.2M
Cap. Flow
% of AUM
8.06%
Top 10 Holdings %
Top 10 Hldgs %
57.21%
Holding
44
New
11
Increased
9
Reduced
8
Closed
9
Top Buys
| 1 |
Merck
MRK
|
$49.6M |
| 2 |
UnitedHealth
UNH
|
$48.9M |
| 3 |
Tenet Healthcare
THC
|
$46.3M |
| 4 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$35.8M |
| 5 |
HCA Healthcare
HCA
|
$23.9M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$39.1M |
| 2 |
MAKO
MAKO SURGICAL CORP COM
MAKO
|
$35.4M |
| 3 |
GIVN
GIVEN IMAGING LTD
GIVN
|
$28.8M |
| 4 |
AstraZeneca
AZN
|
$26M |
| 5 |
Sarepta Therapeutics
SRPT
|
$23.6M |
Sector Composition
| 1 | Healthcare | 92.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $80.2M | 7.07% | 2,000,000 | – | – |
|
2
Viatris
VTRS
$12.3B
| $76M | 6.7% | 1,750,000 -150,000 | -8% | -$6.51M |
|
3
Elevance Health
ELV
$71.8B
| $73.9M | 6.52% | 800,000 -50,000 | -6% | -$4.62M |
|
|
4
HCA Healthcare
HCA
$94.5B
| $59.6M | 5.26% | 1,250,000 +500,000 | +67% | +$23.9M |
|
5
CONMED
CNMD
$1.68B
| $58.9M | 5.19% | 1,385,000 +385,000 | +39% | +$16.4M |
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $52.3M | 4.61% | 1,000,000 +250,000 | +33% | +$13.1M |
|
|
VOLC
7
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $51.3M | 4.53% | 2,350,000 +375,000 | +19% | +$8.19M |
|
|
8
Merck
MRK
$210B
| $49.6M | 4.37% | +990,300 | New | +$49.6M |
|
|
9
UnitedHealth
UNH
$281B
| $48.9M | 4.32% | +650,000 | New | +$48.9M |
|
|
10
Tenet Healthcare
THC
$16.3B
| $46.3M | 4.09% | +1,100,000 | New | +$46.3M |
|
11
Quest Diagnostics
DGX
$20.3B
| $42.8M | 3.78% | 800,000 | – | – |
|
12
Masimo
MASI
$7.59B
| $41.7M | 3.67% | 1,425,000 -325,000 | -19% | -$9.5M |
|
13
Humana
HUM
$36.5B
| $41.3M | 3.64% | 400,000 | – | – |
|
|
ARIA
14
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $35.8M | 3.16% | +5,250,000 | New | +$35.8M |
|
15
Hologic
HOLX
$14.9B
| $33.5M | 2.96% | 1,500,000 -750,000 | -33% | -$16.8M |
|
16
Agilent Technologies
A
$35.7B
| $28.6M | 2.52% | 500,000 | – | – |
|
17
Edwards Lifesciences
EW
$47.8B
| $23M | 2.03% | +350,000 | New | +$23M |
|
18
Community Health Systems
CYH
$387M
| $19.6M | 1.73% | +500,000 | New | +$19.6M |
|
|
UAM
19
DELISTED
Universal American Corp
UAM
| $18.3M | 1.61% | 2,500,000 +1,829,400 | +273% | +$13.4M |
|
20
Novavax
NVAX
$1.21B
| $17.9M | 1.58% | 3,500,000 -1,211,009 | -26% | -$6.2M |
|
21
AngioDynamics
ANGO
$417M
| $17.2M | 1.52% | 1,000,000 -327,500 | -25% | -$5.63M |
|
|
AMRN
22
Amarin Corp
AMRN
$311M
| $16.7M | 1.48% | +8,500,000 | New | +$16.7M |
|
23
Arrowhead Research
ARWR
$3.05B
| $16.3M | 1.44% | 1,500,000 -999,999 | -40% | -$10.8M |
|
24
Cross Country Healthcare
CCRN
$438M
| $15.4M | 1.36% | 1,540,000 | – | – |
|
|
MNTA
25
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $14.1M | 1.25% | 800,000 | – | – |
|